Bristol-Myers Squibb (BMY) Tops Q1 EPS by 28c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.60 --0%
EPS Growth %: +5.5%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Other (income)/expense: -224M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.80, $0.28 better than the analyst estimate of $1.52. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $10.68 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2025 EPS of $6.70-$7.00, versus the consensus of $6.74. Bristol-Myers Squibb sees FY2025 revenue of $45.8-46.8 billion, versus the consensus of $45.76 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- AXG and Digital Realty partner on private infrastructure in 31 markets
- Brinker sets revenue and unit growth targets through fiscal 2029
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
